Skip to main content
. 2022 May 17;9:887067. doi: 10.3389/fcvm.2022.887067

Table 1.

Baseline information of the overall population* .

Total
(n = 117,056)
Normotension
(n = 99,526)
Hypertension
(n = 17,530)
p value
Age (years) 41 (34–53) 39 (33–50) 53 (41–63) <0.001
Female (%) 54,099 (46.2) 48,304 (48.5) 5,795 (33.1) <0.001
Current smoker (%) 6,674 (5.7) 5,520 (5.5) 1,154 (6.6) <0.001
Current drinker (%) 872 (0.7) 651 (0.6) 221 (1.3) <0.001
Family history of diabetes (%) 2,651 (2.3) 2,367 (2.4) 284 (1.6) <0.001
BMI (kg/m2) 23.2 (21–25.5) 22.9 (20.8–25.1) 25.1 (23–27.3) <0.001
FPG (mmol/L) 5.0 (4.61–5.35) 4.95 (4.6–5.3) 5.19 (4.8–5.62) <0.001
ALT (U/L) 18.2 (13–27.8) 18 (12.9–26.8) 22 (15.7–33) <0.001
AST (U/L) 22.0 (18.7–26.9) 21.8 (18.2–26) 24.2 (20.7–29.7) <0.001
BUN (mmol/L) 4.57 (3.85–5.4) 4.53 (3.81–5.35) 4.78 (4.06–5.63) <0.001
Scr (μmol/L) 71.3 (59.3–83.0) 70.5 (58.8–82.4) 75.8 (64.23–86.0) <0.001
Lipid profiles and atherosclerotic indices
TC (mg/dl) 181.70 (159.67–204.90) 179.77 (158.51–202.97) 191.75 (168.56–216.50) <0.001
TG (mg/dl) 97.46 (67.34–146.19) 97.46 (67.34–146.19) 97.46 (67.34–147.08) 0.772
LDL (mg/dl) 104.38 (88.53–121.78) 103.22 (87.76–120.62) 110.95 (93.94–128.74) <0.001
HDL-c (mg/dl) 51.80 (45.23–59.92) 52.19 (45.23–59.92) 51.42 (44.46–59.15) <0.001
Non-HDL-c (mg/dl) 127.96 (108.25–151.16) 126.03 (106.70–148.84) 138.40 (117.53–162.37) <0.001
AC 2.43 (1.95–3.1) 2.38 (1.91–3.04) 2.72 (2.21–3.46) <0.001
AIP 0.28 (0.1–0.47) 0.28 (0.10–0.46) 0.29 (0.11–0.48) <0.001
*

Continuous data are expressed as median (interquartile range) due to the skewed distribution. The p-value is a comparison between the normotension and hypertension groups. FPG, fasting plasma glucose; TG, triglycerides; TC, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; AC, atherogenic coefficient; AIP, atherogenic risk of plasma; Scr, serum creatinine; BUN, blood urea nitrogen; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index.